NORTHAMPTON, MA / ACCESSWIRE / July 11, 2024 / CAREThe transformative power of women entrepreneursBy Sarah Hewitt, Director Strive Women, Women's Entrepreneurship at CAREIn the corner of a vegetarian restaurant in Hanoi's Old Quarter, three Vietnamese women sit around bowls of steaming noodles and dumplings, engrossed in discussion.Despite the noise and chaos of the traffic outside, it's peaceful in this small and cozy restaurant filled with...
Read more
ANGLE plc (AIM:AGL)(OTCQX:ANPCY), a world-leading liquid biopsy company, announces that at the Annual General Meeting of the Company held earlier today, all resolutions were duly passed.For further information:ANGLE plc+44 (0) 1483 343434Andrew Newland, Chief ExecutiveIan Griffiths, Finance Director Berenberg (NOMAD and Broker)Toby Flaux, Ciaran Walsh, Milo Bonser+44 (0) 20 3207 7800FTI ConsultingSimon Conway, Ciara MartinMatthew Ventimiglia...
Read more
BRENTWOOD, TN / ACCESSWIRE / July 11, 2024 / Odyssey Behavioral Healthcare, a leading provider of mental health treatment services, is proud to announce the opening of their new Pasadena Villa Outpatient location in Troy, Michigan. Developed in response to unmet demand for superior mental health treatment services, the facility joins Odyssey's growing network of Pasadena Villa Outpatient locations in Florida, North Carolina, Tennessee, and...
Read more
CRANBURY, NJ / ACCESSWIRE / July 11, 2024 / AcceleDev Chemical LLC, a global leader in custom synthesis services, proudly announces the opening of its state-of-the-art 5,000-square-foot R&D and GMP production facility located at 1 Duncan Drive, Cranbury, New Jersey. This significant expansion marks a new chapter in AcceleDev's mission to provide cutting-edge chemistry solutions and support the development of new medicines.AcceleDev's New R&D/GMP...
Read more
CARDIFF, UK / ACCESSWIRE / July 11, 2024 / Biodexa Pharmaceuticals PLC (NASDAQ:BDRX), an acquisition-focused clinical-stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs, is making good progress with eRapa™, its drug to treat Familial Adenomatous Polyposis (FAP).FAP is a mostly inherited condition that puts people at a much greater risk of developing colorectal...
Read more
New trial date for U.S. patent litigation set for March 3, 2025, following settlement with Acuitas TherapeuticsFirst instance decision on validity of EP 3 708 668 B1 (split poly-A tail technology) scheduled for March 25, 2025, by European Patent Office in the context of the German patent litigationUK trial on validity of intellectual property rights EP 3 708 668 B1 and EP 4 023 755 B1 (split poly-A tail technology) began July 10; judgement...
Read more
Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release second quarter 2024 financial results on Thursday, August 1, 2024. Bausch Health will host a conference call and live webcast at 8:00 a.m. U.S. EST to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.Conference Call DetailsDate:Thursday, August 1,...
Read more
REDWOOD CITY, CA / ACCESSWIRE / July 11, 2024 / Biotricity Inc. (NASDAQ:BTCY), a Technology-as-a-Service (TaaS) company operating in the remote cardiac monitor sector of consumer healthcare, today announced its accelerated timeline to achieving EBITDA positive. The company now expects to reach this significant milestone before the end of calendar 2024, earlier than previously anticipated."Our strategic initiatives and technological advancements...
Read more
NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage global leader in broad-spectrum antiviral nanomedicines, discusses its development program for NV-387, a single drug that has shown activity against many respiratory viral infections in animal models, enabling human clinical trials for a number of indications.There are several viruses that continue to cause epidemics in humans; seasonal epidemics with Influenza, RSV, and...
Read more
Biophytis SA (Euronext Growth Paris:ALBPS), ("Biophytis" or the "Company"), a clinical-stage biotechnology company specialized in the development of therapeutics for age-related diseases, today announced that it has received Investigational New Drug (IND) approval from the Food and Drug Administration (FDA) for its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone).The primary objective of the study is to measure the...
Read more
Gerresheimer, an innovative systems & solutions provider and global partner for the pharma, biotech and cosmetic industries, remains on track in the 1st half of FY 2024. Revenues reached EUR 968.5m (1H 2023: EUR 957.4m), adjusted EBITDA EUR 188.2m (1H 2023: EUR 185.2m). Revenue growth was 1.7% and adjusted EBITDA growth was 2.9% in organic terms. The adjusted EBITDA margin was 19.4%. Destocking effects for customers in the Primary Packaging...
Read more
Exploring Mission Hill Foods' Pursuit of Excellence in Nutrition and Environmental ResponsibilityCALIFORNIA CITY, CA / ACCESSWIRE / July 10, 2024 / Mission Hill Foods, a committed and conscientious provider of science-based dietary nutrition, proudly announces its latest advancements in research, patent achievements, and unwavering commitment to quality, safety, and sustainability.Mission Hill Pioneering Research and Patent AchievementsSince...
Read more
Discover Mission Hill Foods' investment in advanced research, development, and sustainable practices for consumer health.CALIFORNIA CITY, CA / ACCESSWIRE / July 10, 2024 / Mission Hill Foods, a rising star in science-based dietary supplements, announces a major expansion of its research capabilities and strategic initiatives in North America. This move highlights the company's dedication to innovation, quality, and consumer health in the region...
Read more
Innovative Products and Comprehensive Education for Health-Conscious ConsumersCALIFORNIA CITY, CA / ACCESSWIRE / July 10, 2024 / Mission Hill Foods is committed to addressing modern health needs with advanced formulations targeting gut health, vision protection, heart health, and immune support. With a special focus on women's health, Mission Hill Foods has introduced premium products such as Ashwagandha, Evening Primrose Capsules, and Vision...
Read more
Jacksonville has some of the best plastic surgeons in the Southeast. The Review Growth Index™ (RGI™) by Doctor Marketing, MD™ has identified which Jacksonville cosmetic practices made the list for the first quarter of 2024. After analyzing data from over 41 medical practices and 3,412 online Google Reviews, the Top 10 Plastic Surgery and Cosmetic Surgery Clinics in Jacksonville stand out for their patient satisfaction rating and number of online...
Read more
CHICAGO, IL / ACCESSWIRE / July 10, 2024 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary pharmaceutical and nutraceutical brands, manufacturer and distributor of healthcare products, and operator of a telehealth platform, announced today the successful completion of the pilot production and scale-up phases of...
Read moreSALT LAKE CITY, UT / ACCESSWIRE / July 10, 2024 / AVIA Vascular, a pioneering force in the healthcare technology industry, is proud to announce its strategic positioning as a leader in vessel preserving technologies within the vascular access space. With the successful adoption of its current product, The ALLY™ device, AVIA Vascular is revolutionizing phlebotomy and significantly enhancing the patient and provider experience.The ALLY device is...
Read more
GRASS VALLEY, CA / ACCESSWIRE / July 10, 2024 / Applied Science (ASI), the worldwide leader in whole blood collection products and services, today announced that Community Blood Center of the Ozarks (CBCO) has purchased ASI's next-generation device, the HemoFlow 500, and HemoVue, its recently introduced cloud-based service that works with HemoFlow devices to provide real-time operational data and analytics that significantly improve blood...
Read more
CHICAGO, IL / ACCESSWIRE / July 10, 2024 / Renalogic, a leading provider of healthcare solutions for self-funded plans and their members dealing with chronic kidney disease (CKD), partnered with Lyfebulb, a patient empowerment platform that develops and operates the online community TransplantLyfe, to survey dialysis patients to gain valuable insights into the firsthand experiences and challenges of managing this chronic illness. Alarmingly, 62%...
Read more
ROCHESTER, MI / ACCESSWIRE / July 10, 2024 / Clear Vision Center, a premium cataract and LASIK practice serving Metro Detroit, announces the availability of Custom Lens Replacement (CLR) for patients over 45. This procedure offers a long-lasting solution for vision issues related to aging eyes, including presbyopia and early-stage cataracts.Presbyopia is an age-related condition characterized by the gradual loss of the eye's ability to focus on...
Read more
